Prescription Required
Inclusive of all taxes
In Treatment of Bacterial infections CEFACURE REDIMIX 250mg/5ml Oral Liquid is an antibiotic medicine that works by killing the infection-causing bacteria in your body. It is effective for bacterial infections of the throat, ears, urinary tract, skin, and soft tissues. This medicine usually makes you feel better within a few days, but you should continue taking it as prescribed even when you feel better. Stopping it early may make the infection come back and harder to treat.
Consuming alcohol with CEFACURE REDIMIX 250mg/5ml Oral Liquid does not cause any harmful side effects.
CEFACURE REDIMIX 250mg/5ml Oral Liquid is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.
CEFACURE REDIMIX 250mg/5ml Oral Liquid is safe to use during breastfeeding. Human studies suggest that the drug does not pass into the breastmilk in a significant amount and is not harmful to the baby. Avoid prolonged use of CEFACURE REDIMIX 250mg/5ml Oral Liquid, since it may have possible effects such as rash and diarrhea.
CEFACURE REDIMIX 250mg/5ml Oral Liquid does not usually affect your ability to drive.
CEFACURE REDIMIX 250mg/5ml Oral Liquid should be used with caution in patients with severe kidney disease. Dose adjustment of CEFACURE REDIMIX 250mg/5ml Oral Liquid may be needed. Please consult your doctor.
CEFACURE REDIMIX 250mg/5ml Oral Liquid should be used with caution in patients with liver disease. Dose adjustment of CEFACURE REDIMIX 250mg/5ml Oral Liquid may be needed. Please consult your doctor.
If you miss a dose of CEFACURE REDIMIX 250mg/5ml Oral Liquid, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose.
FDC Ltd | B-8, MIDC Area, Waluj - 431 136, Dist. Aurangabad, Maharashtra
Marketer/Manufacturer: Abbott || ₹14.5/tablet (25% cheaper)
No customer reviews yet.
FDA approved prescribing information. Levocitrizine; 1995 [revised May 2007]. [Accessed 01 Apr. 2019] (online) Available from: Read More
European Medicne Agency. Revised assessment report: Ambroxol and bromhexine containing medicinal products. 2015. [Accessed 01 Apr. 2019] (online) Available from: Read More
ScienceDirect. Ambroxol. [Accessed 01 Apr. 2019] (online) Available from: Read More
Levocitrizine. Slough, Berkshire: UCB Pharma Limited; 2007 [revised 27 Mar. 2019]. [Accessed 01 Apr. 2019] (online) Available from: Read More
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Gujarat Terce Laboratories Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Chemo Healthcare Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Sun Pharmaceutical Industries Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Embiotic Laboratories Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Axis Life Science Pvt Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Alembic Pharmaceuticals Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Zee Laboratories || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Natco Pharma Ltd || ₹14.5/tablet (25% cheaper)
Marketer/Manufacturer: Talent Healthcare || ₹14.5/tablet (25% cheaper)